{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:35:57Z","timestamp":1787726157259,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271755, 81871230"],"award-info":[{"award-number":["82271755, 81871230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Peking University People\u2019s Hospital Scientific Research Development Funds","award":["RZ2022-06"],"award-info":[{"award-number":["RZ2022-06"]}]},{"name":"the Open Research Fund of the National Center for Protein Sciences at Peking University in Beijing","award":["KF-202305"],"award-info":[{"award-number":["KF-202305"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12026-024-09522-4","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T10:03:11Z","timestamp":1721815391000},"page":"1238-1246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulating CD8\u2009+\u2009LGALS9\u2009+\u2009T Cell Population Exhibiting Low Cytotoxic Characteristics are Decreased in Patients with Systemic Lupus Erythematosus"],"prefix":"10.1007","volume":"72","author":[{"given":"Qi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayibaota","family":"Bahabayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"issue":"3","key":"9522_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.berh.2017.09.013","volume":"31","author":"MY Choi","year":"2017","unstructured":"Choi MY, et al. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017;31(3):373\u201396.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"9522_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","volume":"43","author":"A Su\u00e1rez-Fueyo","year":"2016","unstructured":"Su\u00e1rez-Fueyo A, Bradley SJ, Tsokos GC. T cells in Systemic Lupus Erythematosus. Curr Opin Immunol. 2016;43:32\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"9522_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang R, et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun. 2021;12(1):832.","journal-title":"Nat Commun"},{"key":"9522_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ebiom.2017.07.018","volume":"22","author":"I Gon\u00e7alves Silva","year":"2017","unstructured":"Gon\u00e7alves Silva I, et al. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells. EBioMedicine. 2017;22:44\u201357.","journal-title":"EBioMedicine"},{"issue":"18","key":"9522_CR5","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1182\/blood-2011-11-389585","volume":"119","author":"S Elahi","year":"2012","unstructured":"Elahi S, et al. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood. 2012;119(18):4192\u2013204.","journal-title":"Blood"},{"issue":"1","key":"9522_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","volume":"127","author":"M Seki","year":"2008","unstructured":"Seki M, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol. 2008;127(1):78\u201388.","journal-title":"Clin Immunol"},{"issue":"12","key":"9522_CR7","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/annrheumdis-2018-213497","volume":"77","author":"LL van den Hoogen","year":"2018","unstructured":"van den Hoogen LL, et al. Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2018;77(12):1810\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"9522_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/art.40467","volume":"70","author":"S Zeggar","year":"2018","unstructured":"Zeggar S, et al. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB\/c Mice in a Pristane-Induced Lupus Model. Arthritis Rheumatol. 2018;70(7):1089\u2013101.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"9522_CR9","doi-asserted-by":"publisher","first-page":"e60807","DOI":"10.1371\/journal.pone.0060807","volume":"8","author":"M Moritoki","year":"2013","unstructured":"Moritoki M, et al. Galectin-9 ameliorates clinical severity of MRL\/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3. PLoS ONE. 2013;8(4):e60807.","journal-title":"PLoS ONE"},{"issue":"5","key":"9522_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4049\/jimmunol.1901114","volume":"204","author":"HY Chen","year":"2020","unstructured":"Chen HY, et al. Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. J Immunol. 2020;204(5):1158\u201372.","journal-title":"J Immunol"},{"key":"9522_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.immunol.21.120601.141114","volume":"21","author":"P Wong","year":"2003","unstructured":"Wong P, Pamer EG. CD8 T cell responses to infectious pathogens. Annu Rev Immunol. 2003;21:29\u201370.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"9522_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/rheumatology\/kex332","volume":"56","author":"HM Kok","year":"2017","unstructured":"Kok HM, et al. Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus. Rheumatology (Oxford). 2017;56(12):2129\u201334.","journal-title":"Rheumatology (Oxford)"},{"key":"9522_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.molimm.2021.09.012","volume":"140","author":"M Bai","year":"2021","unstructured":"Bai M, et al. Impaired granzyme B-producing regulatory B cells in systemic lupus erythematosus. Mol Immunol. 2021;140:217\u201324.","journal-title":"Mol Immunol"},{"issue":"1","key":"9522_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/art.20745","volume":"52","author":"P Blanco","year":"2005","unstructured":"Blanco P, et al. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(1):201\u201311.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"9522_CR15","first-page":"634","volume":"41","author":"M Bai","year":"2023","unstructured":"Bai M, et al. Decreased perforin-producing B cells correlate with systemic lupus erythematosus. Clin Exp Rheumatol. 2023;41(3):634\u201341.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"9522_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1600-6143.2007.02128.x","volume":"8","author":"LG Hidalgo","year":"2008","unstructured":"Hidalgo LG, et al. The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells. Am J Transplant. 2008;8(3):627\u201336.","journal-title":"Am J Transplant"},{"issue":"1","key":"9522_CR17","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1038\/s41467-019-10018-1","volume":"10","author":"KL Truong","year":"2019","unstructured":"Truong KL, et al. Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4(+) memory T cells. Nat Commun. 2019;10(1):2263.","journal-title":"Nat Commun"},{"key":"9522_CR18","doi-asserted-by":"crossref","unstructured":"Li Q, Yuan Z, Bahabayi A, Zhang Z, Zeng X, Kang R, Liu C et al. Upregulation of CX3CR1 expression in\u00a0circulating T cells of systemic lupus erythematosus patients as a reflection of autoimmune status through\u00a0characterization of cytotoxic capacity. Int Immunopharmacol. 2024;126:111231.","DOI":"10.1016\/j.intimp.2023.111231"},{"issue":"4","key":"9522_CR19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4049\/jimmunol.2101048","volume":"211","author":"C Liu","year":"2023","unstructured":"Liu C, et al. G Protein-Coupled Receptor 56 Characterizes CTLs and Reflects the Progression of Lung Cancer Patients. J Immunol. 2023;211(4):683\u201392.","journal-title":"J Immunol"},{"key":"9522_CR20","first-page":"451694","volume":"2011","author":"KA Hofmeyer","year":"2011","unstructured":"Hofmeyer KA, Jeon H, Zang X. The PD-1\/PD-L1 (B7\u2013H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion. J Biomed Biotechnol. 2011;2011:451694.","journal-title":"J Biomed Biotechnol"},{"issue":"12","key":"9522_CR21","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.4049\/jimmunol.2100138","volume":"207","author":"BP Nicolet","year":"2021","unstructured":"Nicolet BP, Guislain A, Wolkers MC. CD29 Enriches for Cytotoxic Human CD4(+) T Cells. J Immunol. 2021;207(12):2966\u201375.","journal-title":"J Immunol"},{"issue":"9","key":"9522_CR22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"9522_CR23","doi-asserted-by":"publisher","first-page":"e13038","DOI":"10.1111\/sji.13038","volume":"94","author":"F Qiu","year":"2021","unstructured":"Qiu F, et al. CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis. Scand J Immunol. 2021;94(1):e13038.","journal-title":"Scand J Immunol"},{"issue":"5","key":"9522_CR24","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bj.2021.04.012","volume":"44","author":"AK Singh","year":"2021","unstructured":"Singh AK, Lin HH. The role of GPR56\/ADGRG1 in health and disease. Biomed J. 2021;44(5):534\u201347.","journal-title":"Biomed J"},{"issue":"8","key":"9522_CR25","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.celrep.2016.04.053","volume":"15","author":"GW Chang","year":"2016","unstructured":"Chang GW, et al. The Adhesion G Protein-Coupled Receptor GPR56\/ADGRG1 Is an Inhibitory Receptor on Human NK Cells. Cell Rep. 2016;15(8):1757\u201370.","journal-title":"Cell Rep"},{"issue":"2","key":"9522_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","volume":"41","author":"C Wu","year":"2014","unstructured":"Wu C, et al. Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity. 2014;41(2):270\u201382.","journal-title":"Immunity"},{"issue":"1","key":"9522_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13073-021-00918-7","volume":"13","author":"M Miron","year":"2021","unstructured":"Miron M, et al. Maintenance of the human memory T cell repertoire by subset and tissue site. Genome Med. 2021;13(1):100.","journal-title":"Genome Med"},{"key":"9522_CR28","first-page":"v","volume":"1186","author":"E Ranieri","year":"2014","unstructured":"Ranieri E. Preface. Cytotoxic T-cells. Methods Mol Biol. 2014;1186:v.","journal-title":"Methods Mol Biol"},{"key":"9522_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jaut.2013.06.004","volume":"45","author":"DM Gravano","year":"2013","unstructured":"Gravano DM, Hoyer KK. Promotion and prevention of autoimmune disease by CD8+ T cells. J Autoimmun. 2013;45:68\u201379.","journal-title":"J Autoimmun"},{"issue":"1","key":"9522_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12974-023-02810-0","volume":"20","author":"Z Shi","year":"2023","unstructured":"Shi Z, et al. Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression. J Neuroinflammation. 2023;20(1):138.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"9522_CR31","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1038\/s41598-021-85152-2","volume":"11","author":"J Sun","year":"2021","unstructured":"Sun J, et al. Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis. Sci Rep. 2021;11(1):5562.","journal-title":"Sci Rep"},{"issue":"1","key":"9522_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227069","volume":"15","author":"N Matsuoka","year":"2020","unstructured":"Matsuoka N, et al. Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus. PLoS ONE. 2020;15(1): e0227069.","journal-title":"PLoS ONE"},{"issue":"5","key":"9522_CR33","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1172\/JCI97333","volume":"128","author":"SK Panda","year":"2018","unstructured":"Panda SK, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128(5):1873\u201387.","journal-title":"J Clin Invest"},{"issue":"6","key":"9522_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/acr.23021","volume":"69","author":"F Rees","year":"2017","unstructured":"Rees F, et al. Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model. Arthritis Care Res (Hoboken). 2017;69(6):833\u201341.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-024-09522-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:06:57Z","timestamp":1733270817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-024-09522-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9522"],"URL":"https:\/\/doi.org\/10.1007\/s12026-024-09522-4","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All research protocols received approval from the Ethics Committee of Peking University People's Hospital and adhered strictly to the ethical standards outlined in the Helsinki Declaration. Furthermore, informed consent was obtained from all individuals participating in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}]}}